Medicare billing address
CMS Medicare provider billing file
1055 N 300 W Ste 500Provo, UT 84604
CMS public data · NPI 1376981894
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Robert J Welch, MD
Specialty
Credential
MD
NPI
1376981894
Primary source state
UT
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Robert J Welch, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1055 N 300 W Ste 500CMS Doctors & Clinicians file
11820 S State StIn the 2024 CMS provider billing file, this NPI had 686 Medicare beneficiaries and 46,269 total services. The average beneficiary age was 78, and the average HCC risk score was 1.5.
Total Medicare allowed amount
$3,293,142.15
Total Medicare payment amount
$2,584,856.39
Medicare beneficiaries
686
Total services
46,269
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
71%
CMS beneficiary-panel share
Hyperlipidemia
67%
CMS beneficiary-panel share
Diabetes
31%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Ischemic heart disease
25%
CMS beneficiary-panel share
Atrial fibrillation
20%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 38,160 | $34.33 |
| Imaging of retina | 2,238 | $39.79 |
| Injection of drug into eye | 1,454 | $125.56 |
| Injection, aflibercept, 1 mg | 1,420 | $820.44 |
| Injection, aflibercept hd, 1 mg | 440 | $318.97 |
| Injection, ranibizumab, 0.1 mg | 425 | $157.05 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 309 | $90.45 |
| Established patient complete exam of visual system | 282 | $127.12 |
| Compounded drug, not otherwise classified | 188 | $91.60 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 175 | $202.32 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1376981894. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisolone Acetate | Prednisolone Acetate | 189 | 275.3 | $9,271.62 |
| 2 | Ofloxacin | Ofloxacin | 86 | 86.3 | $1,008.17 |
| 3 | Atropine Sulfate | Atropine Sulfate | 80 | 111.4 | $2,456.43 |
| 4 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 72 | 174.9 | $992.36 |
| 5 | Ketorolac Tromethamine | Ketorolac Tromethamine | 47 | 74.6 | $1,026.75 |
| 6 | Latanoprost | Latanoprost | 27 | 62.6 | $161.90 |
| 7 | Brimonidine Tartrate | Brimonidine Tartrate | 22 | 38.9 | $182.86 |
| 8 | Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 17 | 17 | $330.40 |
| 9 | Timolol Maleate | Timolol Maleate | 17 | 42.3 | $176.68 |
| 10 | Bromfenac Sodium | Bromfenac Sodium | 14 | 17.5 | $1,894.31 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Utah School Of Medicine
Graduation year
2012
Group/practice field
Retina And Vitreous Surgeons Of Utah Llc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.